Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Reporter Kim Jisun / approved : 2024-08-14 03:32:54
  • -
  • +
  • 인쇄

Seo Jung-jin, honorary chairman of Celltrion (photo= Celltrion)

 

[Alpha Biz= Reporter Kim Jisun] Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Celltrion announced on August 13 that its self-immune disorder treatment, Yuflyma (ingredient: adalimumab), is now available for purchase at Costco, a major U.S. retailer. The drug was registered with the Costco Member Prescription Program (CMPP) as of August 1 (local time).

The CMPP allows Costco members to buy medications at discounted prices from in-store or affiliated pharmacies. Starting this month, uninsured Costco members and their dependents can purchase Low WAC Yuflyma at a reduced price from Costco stores and partner pharmacies across the U.S.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Samsung C&T Successfully Monetizes Australian Solar and ESS Project, Expanding Renewable Gains Beyond the U.S.2026.02.05
Prosecutors Expand Probe into Misappropriation of Corporate Funds by Former Namyang Dairy Chairman Hong Won-sik and Family2026.02.05
Coupang App Downloads Plunge 11% Following Data Breach, Naver Plus Store Gains Momentum2026.02.05
Beanpole Removes 2026 Spring Collection Teaser Featuring Kim Seon-ho2026.02.05
National Health Insurance Service Files Appeal with Supreme Court in Tobacco Lawsuit2026.02.05
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사